PA
ISSC icon

PharVision Advisers’s Innovative Solutions & Support ISSC Stock Holding History

PharVision Advisers’s Portfolio ISSC Stock Details ISSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-17,274
Closed -$327K – 375
2025
Q4 		$327K Buy
+17,274
New +$197K 0.17% 229

Other funds holding ISSC

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PharVision Advisers's ISSC Position: Q1 2026 in Review

PharVision Advisers sold out of Innovative Solutions & Support (ISSC) in Q1 2026, closing a stake of 17,274 shares — an estimated $327K sold.

PharVision Advisers first reported a position in ISSC in Q4 2025 and held it in 1 quarter. The position peaked at $327K in Q4 2025. 123 funds tracked by Wall St. Rank hold ISSC as of Q1 2026.

  • PharVision Advisers reported no remaining Innovative Solutions & Support position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 17,274 Innovative Solutions & Support shares in Q1 2026, an estimated $327K.
  • PharVision Advisers first reported a position in Innovative Solutions & Support in Q4 2025 and held it in 1 quarter.
  • PharVision Advisers's Innovative Solutions & Support position peaked at $327K in Q4 2025.
  • 123 funds tracked by Wall St. Rank held Innovative Solutions & Support as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.